These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 7540521)

  • 21. [Recent advances in paraneoplastic encephalomyeloneuronopathy].
    Sakai K
    Nihon Rinsho; 1994 Nov; 52(11):3006-12. PubMed ID: 7996702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selection of recombinant anti-HuD Fab fragments from a phage display antibody library of a lung cancer patient with paraneoplastic encephalomyelitis.
    Graus YF; Verschuuren JJ; Degenhardt A; van Breda Vriesman PJ; De Baets MH; Posner JB; Burton DR; Dalmau J
    J Neuroimmunol; 1998 Mar; 82(2):200-9. PubMed ID: 9585817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-neuronal autoantibodies and neurological paraneoplastic syndromes.
    Anderson NE
    Aust N Z J Med; 1989 Aug; 19(4):379-87. PubMed ID: 2675816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The onconeural antigen Nova-1 is a neuron-specific RNA-binding protein, the activity of which is inhibited by paraneoplastic antibodies.
    Buckanovich RJ; Yang YY; Darnell RB
    J Neurosci; 1996 Feb; 16(3):1114-22. PubMed ID: 8558240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conflicting consequences of immunity to cancer versus autoimmunity to neurons: insights from paraneoplastic disease.
    Steinman L
    Eur J Immunol; 2014 Nov; 44(11):3201-5. PubMed ID: 25319369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paraneoplastic neurologic syndromes.
    Hirose G
    Intern Med; 1996 Dec; 35(12):925-9. PubMed ID: 9030988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunological mechanisms in paraneoplastic peripheral neuropathy.
    Antoine JC
    Clin Rev Allergy Immunol; 2000 Aug; 19(1):61-72. PubMed ID: 11064827
    [No Abstract]   [Full Text] [Related]  

  • 28. [Autoimmunity and paraneoplastic neurologic syndromes].
    Delattre JY; Davila L; Vega F; Poisson M
    Rev Neurol (Paris); 1991; 147(8-9):549-56. PubMed ID: 1962063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoimmune pathogenesis of paraneoplastic neurological syndromes.
    Anderson NE; Cunningham JM; Posner JB
    Crit Rev Neurobiol; 1987; 3(3):245-99. PubMed ID: 3315239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paraneoplastic syndromes.
    Posner JB; Furneaux HM
    Res Publ Assoc Res Nerv Ment Dis; 1990; 68():187-219. PubMed ID: 2183311
    [No Abstract]   [Full Text] [Related]  

  • 31. T cells targeting a neuronal paraneoplastic antigen mediate tumor rejection and trigger CNS autoimmunity with humoral activation.
    Blachère NE; Orange DE; Santomasso BD; Doerner J; Foo PK; Herre M; Fak J; Monette S; Gantman EC; Frank MO; Darnell RB
    Eur J Immunol; 2014 Nov; 44(11):3240-51. PubMed ID: 25103845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical relevance of non-neuronal auto-antibodies in patients with anti-Hu or anti-Yo paraneoplastic diseases.
    Aguirre-Cruz L; Charuel JL; Carpentier AF; Benyahia B; Delattre JY; Musset L
    J Neurooncol; 2005 Jan; 71(1):39-41. PubMed ID: 15719273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of antineuronal antibodies from patients with paraneoplastic neurological syndrome on primary-cultured neurons.
    Tanaka K; Ding X; Tanaka M
    J Neurol Sci; 2004 Jan; 217(1):25-30. PubMed ID: 14675605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paraneoplastic syndromes of the nervous system.
    Posner JB; Dalmau JO
    Clin Chem Lab Med; 2000 Feb; 38(2):117-22. PubMed ID: 10834398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HLA antigens in paraneoplastic cerebellar degeneration associated with anti-Yo antibody.
    Tanaka M; Tanaka K; Tsuji S
    Neurodegeneration; 1994 Dec; 3(4):341-2. PubMed ID: 7842305
    [No Abstract]   [Full Text] [Related]  

  • 36. [Paraneoplastic neurological autoimmune diseases].
    Voltz R
    Dtsch Med Wochenschr; 2004 Aug; 129(33):1743-6. PubMed ID: 15295685
    [No Abstract]   [Full Text] [Related]  

  • 37. Cytotoxic T cells react with recombinant Yo protein from a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody.
    Tanaka M; Tanaka K; Shinozawa K; Idezuka J; Tsuji S
    J Neurol Sci; 1998 Nov; 161(1):88-90. PubMed ID: 9879687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuronal uptake of anti-Hu antibody, but not anti-Ri antibody, leads to cell death in brain slice cultures.
    Greenlee JE; Clawson SA; Hill KE; Wood B; Clardy SL; Tsunoda I; Jaskowski TD; Carlson NG
    J Neuroinflammation; 2014 Sep; 11():160. PubMed ID: 25228406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paraneoplastic neurologic disorders: windows into neuronal function and tumor immunity.
    Darnell RB
    Arch Neurol; 2004 Jan; 61(1):30-2. PubMed ID: 14732616
    [No Abstract]   [Full Text] [Related]  

  • 40. Cell-mediated autoimmunity in paraneoplastic neurological syndromes with anti-Hu antibodies.
    Benyahia B; Liblau R; Merle-Béral H; Tourani JM; Dalmau J; Delattre JY
    Ann Neurol; 1999 Feb; 45(2):162-7. PubMed ID: 9989617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.